Annals of Internal Medicine Publishes 12-Month Results from LivaNova’s OSPREY Clinical Study for Obstructive Sleep Apnea

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. GOOGL
5. APGE
6. MU
7. HOOD
8. DFTX
9. USO
10. RGNX

Go back to Annals of Internal Medicine Publishes 12-Month Results from LivaNova’s OSPREY Clinical Study for Obstructive Sleep Apnea
(NASDAQ: LIVN) Delayed: 79.13 +0.63 (0.80%)
Previous Close $78.50    52 Week High $63.21 
Open $78.65    52 Week Low $41.17 
Day High $79.89    P/E N/A 
Day Low $77.74    EPS $0.00 
Volume 204,387